Director Robert C. Patent sold 14,445 shares of MCB for $1,360,130.93 in 6 separate transactions at blended avg $94.16 on Jan 22-23.
Director Robert C. Patent executed 6 separate sales across two days totaling 14,445 shares for $1,360,130.93, reducing his holding from 101,185 shares to 86,740 shares (-14.3% of pre-transaction holdings). The sales occurred at prices ranging from $90.04 to $96.16, with a blended average of $94.16, above the current price of $88.77 and near the 52-week high of $94.95. The company is trading at a P/E of 14.36 with recent quarterly results showing net income of $7,119,000.00 against revenue of $2,485,000.00, though annual revenue growth declined -14.2% year-over-year. The filing discloses a material insider reduction of over 14% of prior holdings executed around historical price levels.